Dimethylamine

Dimethylamine

SCHEMBL4059229

CNC.FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)c1ccccc1

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KCNN4 O15554 5/20 0.41
TSHR P16473 3/20 0.41
ALDH1A1 P00352 1/20 0.41
PTPN1 P18031 1/20 0.33
CA1 P00915 2/20 0.32
CA2 P00918 2/20 0.32
CA5A P35218 1/20 0.32
CA9 Q16790 1/20 0.32
MAPK1 P28482 1/20 0.32
LMNA P02545 1/20 0.32
NR1H2 P55055 2/20 0.32
NR1H3 Q13133 2/20 0.32
KIF11 P52732 1/20 0.31
PDK1 Q15118 2/20 0.31
PDK2 Q15119 2/20 0.31
PDK3 Q15120 2/20 0.31
PDK4 Q16654 2/20 0.31
NR3C2 P08235 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1421315 0.91 TSHR (0.48) KCNN4TSHRALDH1A1PTPN1CA1
SCHEMBL9800786 0.91 TSHR (0.48) KCNN4TSHRALDH1A1PTPN1CA1
SCHEMBL1421122 0.91 TSHR (0.48) KCNN4TSHRALDH1A1PTPN1CA1
SCHEMBL15320774 0.91 TSHR (0.48) KCNN4TSHRALDH1A1PTPN1CA1
SCHEMBL10453463 0.91 TSHR (0.48) KCNN4TSHRALDH1A1PTPN1CA1
SCHEMBL3390346 0.89 TSHR (0.50) KCNN4TSHRALDH1A1PTPN1CA1
SCHEMBL30619668 0.84 TSHR (0.55) KCNN4TSHRALDH1A1PTPN1CA1
SCHEMBL11696796 0.82 TSHR (0.52) KCNN4TSHRALDH1A1PTPN1CA1
SCHEMBL673282 0.79 LMNA (0.43) CA1CA2LMNANR1H2NR1H3
SCHEMBL1421311 0.79 KIF11 (0.56) TSHRALDH1A1PTPN1MAPK1KIF11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7553988-B2 Method for producing coupling compound SUMITOMO CHEMICAL COMPANY, LIMTED (JP) 2009-06-30 US disclosed
EP-1439157-B1 Method for producing Suzuki coupling compound catalysed by a nickel compound SUMITOMO CHEMICAL CO (JP) 2007-07-11 EP disclosed
US-7238832-B2 Production method of a coupling compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-07-03 US disclosed
US-7217677-B2 Method for producing coupling compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-05-15 US disclosed
US-20060281925-A1 METHOD FOR PRODUCING COUPLING COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2006-12-14 US disclosed
EP-1449580-B1 Production method of a cross-coupling compound from an alkyl halide and an organoboron compound SUMITOMO CHEMICAL CO (JP) 2005-12-28 EP disclosed
US-20040167364-A1 Production method of a coupling compound SUMITOMO CHEMICAL COMPANY, LIMITED 2004-08-26 US disclosed
EP-1449580-A1 Production method of a cross-coupling compound from an alkyl halide and an organoboron compound Sumitomo Chemical Co.,Ltd. (JP) 2004-08-25 EP disclosed
US-20040161404-A1 Method for producing coupling compound SUMITOMO CHEMICAL COMPANY, LIMITED 2004-08-19 US disclosed
EP-1439157-A2 Method for producing Suzuki coupling compound catalysed by a nickel compound Sumitomo Chemical Co.,Ltd. (JP) 2004-07-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040167364-A1 Production method of a coupling compound PYM1, BRIX1, CXCR1 KCNN4 579/4885TSHR 447/4885ALDH1A1 3812/4885
US-20060281925-A1 METHOD FOR PRODUCING COUPLING COMPOUND RPL22, CYP4A22, PYM1 KCNN4 86/4885TSHR 711/4885ALDH1A1 3831/4885
US-20040161404-A1 Method for producing coupling compound PYM1, MALT1, BET1 KCNN4 262/4885TSHR 423/4885ALDH1A1 3550/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.